홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dimethyl Sulfoxide → N-[(1-carbamimidoylpiperidin-4-yl)methyl]-3-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxybenzamide

HRID 2114810
인쇄

반응식

HRID 2114810 반응식
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[CH2:9][CH2:10][O:11][C:12]1[CH:13]=[C:14]([CH:18]=[CH:19][C:20]=1[O:21][CH3:22])[C:15]([OH:17])=O.C(N1C=CN=C1)(N1C=CN=C1)=O.Cl.[NH2:36][CH2:37][CH:38]1[CH2:43][CH2:42][N:41]([C:44]([NH2:46])=[NH:45])[CH2:40][CH2:39]1.CS(C)=O>CN(C=O)C>[C:44]([N:41]1[CH2:42][CH2:43][CH:38]([CH2:37][NH:36][C:15](=[O:17])[C:14]2[CH:18]=[CH:19][C:20]([O:21][CH3:22])=[C:12]([O:11][CH2:10][CH2:9][C:3]3[CH:4]=[CH:5][C:6]([Cl:8])=[CH:7][C:2]=3[Cl:1])[CH:13]=2)[CH2:39][CH2:40]1)(=[NH:45])[NH2:46]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 679Dimethyl SulfoxideHCID 682631,1'-CarbonyldiimidazoleHCID 154803323-[2-(2,4-Dichlorophenyl)ethoxy]-4-methoxybenzoic acidHCID 177949434-Aminomethyl-piperidine-1-carboxamidine hydrochloride

생성물 1

HCID 10162765N-[(1-carbamimidoylpiperidin-4-yl)methyl]-3-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxybenzamide수율 21.4%

시약·촉매·용매

1
HCID 6228Dimethylformamide용매

실험 절차

A solution of 100 mg 3-[2-(2,4-Dichlorophenyl)-ethoxy]-4-methoxy-benzoic acid in 2 ml DMF was activated by the addition of 53 mg carbonyldiimidazole. After stirring for 2 h at RT 90 mg of 4-Aminomethyl-piperidine-1-carboxamidine hydrochloride and 2 ml DMSO were added and the mixture was stirred overnight. Subsequent dilution with 3 ml water and filtration through a chem elut® cartridge, eluting with ethyl acetate yielded after concentration under reduced pressure a white solid. Purification by preparative HPLC (C18 reverse phase column, elution with a H2O/MeCN gradient with 0.5% TFA) and lyophilisation afforded 30 mg (20%) of the title compound as a white powder.

후처리

  1. additionwere added
  2. filtrationSubsequent dilution with 3 ml water and filtration through a chem elut® cartridge
  3. washeluting with ethyl acetate
  4. customyielded
  5. concentrationafter concentration under reduced pressure a white solid
  6. customPurification by preparative HPLC (
  7. washC18 reverse phase column, elution with a H2O/MeCN gradient with 0.5% TFA) and lyophilisation

출처 및 근거

ORD 기록
ord-343486162e4f459a8379f6a34dbc91d1
출처 데이터셋
uspto-grants-2008_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07435747B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트